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intraocular lens (ioL) exchange after cataract surgery is unusual but may be associated with suboptimal 
visual outcome. the incidence of ioL exchange has not been consistently estimated. Such information 
is invaluable when counseling patients prior to cataract surgery. We examined the incidence of, and 
indications and risk factors for, ioL exchange after cataract surgery. We also assessed visual outcome 
of eyes that had an ioL exchange. A cohort design was used to estimate the incidence of ioL exchange 
and a case-control design to identify factors associated with it. All phacoemulsification surgeries with 
ioL (n = 17415 eyes) during 2010–2017 and those that had a subsequent IOL removal or replacement 
during the same time period were identified (n = 34 eyes). The incidence of IOL exchange was 2 per 
1000 surgeries (95% confidence interval [CI] 1 to 3) over 8 years. Eyes that underwent subsequent 
ioL removal or replacement were compared with eyes that had cataract surgery only (n = 47) across 
demographic and clinical characteristics. in a binary logistic regression analysis, two factors were 
significantly associated with IOL exchange/removal: an adverse event during cataract surgery (adjusted 
odds ratio [aOR] 19.45; 95% CI 4.89–77.30, P < 0.001) and a pre-existing ocular comorbidity (aOR 10.70; 
95% CI 1.69–67.63, P = 0.021). The effect of gender was marginally significant (P = 0.077). Eyes that 
underwent IOL exchange or explantation were nearly two and a half times more likely to have a final 
best-corrected visual acuity of <20/60 compared to those that had cataract surgery alone (adjusted RR 
2.60 95% CI, 1.13–6.02; P = 0.025).
Age-related cataract remains the leading cause of blindness worldwide, despite the fact that cataract surgery is 
one of the most frequently performed and cost effective surgical interventions to date1–5. The outcomes of cataract 
surgery are generally very good. However, potentially vision-threatening complications may occur in a small pro-
portion of patients. Most of these complications (estimated incidence) have been extensively studied including 
endophthalmitis (0.05–0.15%)6, retinal detachment (0.39%)7, and expulsive hemorrhage (0.05–0.1%)8. Seemingly 
less severe and often seen as a late complication, the need for intraocular lens (IOL) exchange after primary cata-
ract surgery is unusual and may lead to suboptimal visual outcome9–15. However the incidence of this surgery has 
not been consistently estimated previously. Here, we studied the incidence of IOL exchange among patients that 
had primary surgery at a single center over a period of 8 years. We also examined the risk factors for, and visual 
outcomes after intraocular lens (IOL) removal/exchange after cataract surgery.
Results
incidence of ioL exchange. During 2010–2017, a total of 17415 eyes underwent phacoemulsification with 
IOL implantation in King Khaled Eye Specialist Hospital (KKESH). Of these, we initially identified 45 eyes of 45 
patients who had IOL removal or exchange in the same period. Eleven eyes (of 11 patients) were excluded because 
these had phakic IOL removal with cataract surgery. Thus 34 eyes (of 34 patients) that underwent subsequent 
IOL removal or replacement during same period remained, equaling an overall cumulative incidence of IOL 
exchange/explantation of 2 per 1000 surgeries (95% confidence interval [CI] 1 to 3).
Characteristics of eyes/individuals with IOL exchange/explantation and their controls. The 
demographic and clinical information for cases and controls is summarized in Table 1. Briefly, individuals/eyes 
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that underwent IOL exchange/ex-plantation were almost comparable to controls in terms of most characteristics 
(i.e., age, pre-existing systemic comorbidities, and operated eye), except that eyes with IOL exchange had a greater 
mean axial length and a higher burden of pre-existing ocular comorbidities such as glaucoma (3 eyes), high myo-
pia (2 eyes), and uveitis, pseudoexfoliation and Fuchs’ dystrophy and previous intraocular surgery (1 eye each) 
compared to control eyes.
Factors associated with of IOL exchange/explantation. In the multivariable binary logistic regres-
sion analysis (Table 2), an adverse event during cataract surgery and a pre-existing ocular comorbidity were 
significantly associated with the outcome. The effect of gender was marginally significant and that of axial length 
was not statistically significant. Briefly, the risk of IOL exchange/explantation was higher among eyes with an 
eventful cataract surgery (adjusted odds ratio [aOR] 19.45; 95% CI 4.89–77.30, P < 0.001); among those with 
a pre-existing ocular comorbidity (aOR 10.70; 95% CI 1.69–67.63, P = 0.012), among males (aOR 2.94; 95% CI 
0.89–9.73, P = 0.077), and among eyes with an axial length of ≥26 mm (aOR 2.92; 95% CI 0.75 11.28 P = 0.121), 
compared with their reference groups.
indication for ioL exchange and location of re-implanted ioL. The most frequent indications for 
IOL exchange (Table 3) were: In-the-bag subluxation in 8 eyes (23.5%), out-of-the bag subluxation and refractive 
error in 7 each (20.6% each) and uveitis in 6 (17.6%). Of 7 eyes with refractive error, 4 eyes had undergone a pre-
vious myopic LASIK (laser in situ keratomileusis) procedure. Of the 3 remaining eyes, one had preoperative axial 
length measure using ultrasound instead of optical biometry, because of mature cataract. The remaining 2 eyes 
had received the wrong IOL power without any clear reason. For all the 7 eyes that were given wrong IOL power, 
the final IOL position (after IOL exchange) was in the bag.
Of the explanted IOLs, 25 were one-piece acrylic hydrophobic, 2 were three-piece acrylic hydrophobic and 7 
were one-piece polymethyl methacrylate. The most frequent locations of the re-implanted IOLs were: sulcus in 9 
eyes (26.5%), in-the-bag in 8 (23.5%), iris fixated and scleral fixated in 5 each (14.7% each) and anterior chamber 
in 4 (11.8%).
Anterior vitrectomy and pars plana vitrectomy (PPV) were needed at the time of IOL exchange in 5 and 6 
eyes, respectively, where PPV alone was done for those that had posterior IOL dislocation. Another 2 eyes needed 
subsequent PPV for reasons unrelated to the IOL exchange; 1 of these for diabetes tractional detachment and 
vitreous hemorrhage and 1 for panuveitis.
Characteristic
IOL exchange/explantation 
group n = 34
Control group 
n = 47
Freq % Freq %
Age (years)* 58.32 ± 13.51 58.26 ± 16.41
Gender
  Male 20 58.8 22 46.8
  Female 14 41.2 25 53.2
Eye
  Right 23 67.6 26 55.3
  Left 11 32.4 21 44.7
Pre-existing systemic comorbidity†
  Yes 24 70.6 36 76.6
  No 10 29.4 11 23.4
Pre-existing ocular comorbidity‡
  Yes 7 20.6 2 4.3
  No 27 79.4 45 95.7
Axial length (millimeter)* 25.10 ± 2.14 24.10 ± 1.68
Adverse event during cataract surgery§
  Yes 17 50 4 8.5
  No 17 50 43 91.5
Type of surgery
  Phacoemulsification 20 58.8 43 91.5
  Phaco + vitrectomy/other procedure 14 41.2 4 8.5
IOL position
  In the bag 25 73.5 44 93.6
  Anterior chamber/sulcus 9 26.5 3 6.4
Table 1. Characteristics of cases and controls. *Data are presented as means and SD. †Frequent systemic 
comorbidities included diabetes and hypertension. ‡Pre-existing ocular comorbidities included glaucoma, 
high myopia, previous intraocular surgery, uveitis, pseudoexfoliation and Fuchs’ dystrophy. §Frequent adverse 
events during cataract surgery included posterior capsular tear with or without vitreous prolapse, or subluxated 
intraocular lens.
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Visual outcome of IOL exchange/explantation. A higher proportion of eyes that underwent IOL 
exchange or explantation had suboptimal vision (best corrected visual acuity [BCVA] <20/60) than the control 
eyes at the most recent visit (Table 4). Eyes that underwent IOL exchange or explantation were three times (crude 
relative risk [RR] 3.11 [95% CI, 1.35–7.15]; P = 0.008) more likely to have a BCVA of <20/60 than those that had 
cataract surgery alone. This relative risk remained high and statistically significant even after adjustment for base-
line BCVA (adjusted RR 2.60 [95% CI, 1.13–6.02]; P = 0.025).
Discussion
Several retrospective studies have looked at the risk factors for and visual outcomes after IOL removal/
exchange10–15. However, to the best of our knowledge this is the first study to report the incidence of IOL removal/
exchange (2 per 1000 cataract surgeries (95% confidence interval [CI] 1 to 3, over 8 years, corresponding to an 
average annual incidence of 2.5 per 10,000). This information is invaluable for counseling patients prior to cata-
ract surgery about the risk of an IOL exchange and its sequelae.
IOL removal/exchange incidence estimates that exist in the literature are all based on one specific subgroup 
of these patients; namely those that had late IOL dislocations16–20. Furthermore, most of the patients exam-
ined in those studies only needed IOL repositioning as opposed the exchange or replacement17–20. Focusing on 
late IOL dislocation, Clark et al. reported the 5-year cumulative incidence of IOL dislocation to be 0.3% in a 
population-based study, with an increase in the rate of this complication during a study period of 22 years16. This 
figure is somewhat higher compared to our study (0.2% over 8 years). However, it is notable that Clark et al. did 
not mention the degree of dislocation and whether IOL exchange was required or not16.
Jakobsson et al. characterized the risk factors of late IOL dislocation in a sample of 84 eyes, finding an over-
representation of pseudoexfoliation (PXF), glaucoma and cataract surgeries complicated by zonular dehiscence17. 
They used data from the Swedish National Cataract Register between 2004 and 2006 to estimate the incidence of 
IOL repositioning surgery, by dividing the number of IOL repositioning surgeries by the total number of pseu-
dophakic individuals during the same period, arriving at an annual incidence of 0.05%, which is slightly higher 
than the average annual incidence described in our study (0.025%)17. However only 7% of their patients required 
IOL exchange or removal and the remaining patients had scleral suturing of the dislocated IOL17. Monestam et 
al. followed 810 patients for 10 years after cataract surgery and identified 5 patients that required further surgery 
Characteristic Crude OR (95% CI) P Adjusted OR (95% CI) P
Age, years
  ≤59 1.28 (0.53–3.10) 0.586
  ≥60 1.0
Gender
  Male 1.62 (0.67–3.96) 0.287 2.94 (0.89–9.73) 0.077
  Female 1.0
Eye
  Right 1.69 (0.67–4.24) 0.264
  Left 1.0
Pre-existing systemic comorbidity*
  Yes 0.73 (0.27–1.99) 0.543
  No 1.0
Pre-existing ocular comorbidity†




  ≥26 2.38 (0.80–7.09) 0.150 2.92 (0.75–11.28) 0.121
Adverse event during cataract surgery‡




  Phaco + vitrectomy/other procedure 7.53 (2.20–25.78) 0.001
IOL position
  In the Bag 1.0
  Anterior chamber/sulcus 5.28 (1.31–21.32) 0.019
Table 2. Bivariate and multivariable binary logistic regression analysis of factors associated with IOL exchange/
explantation. *Frequent systemic comorbidities included diabetes and hypertension. †Pre-existing ocular 
comorbidities included glaucoma, high myopia, previous intraocular surgery uveitis, pseudoexfoliation and 
Fuchs’ dystrophy. ‡Frequent adverse events during cataract surgery included posterior capsular tear with or 
without vitreous prolapse, or subluxated intraocular lens.
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for dislocated IOL, resulting in a 10 year incidence of 0.6% for this complication18. Kinga Dabrowska-Kloda et al. 
estimated the annual incidence of late in-the-bag IOL dislocation over a 21-year period, reviewing 123 patients 
(eyes) and an equal number of controls, and data from the Swedish National Cataract Registry and life tables from 
official statistics on the Swedish population19. The annual incidence varied between 0 and 0.08%. The cumulative 
risk was 0.09% and 0.55% over 5 and 10 years, respectively. Risk factors included PXF, zonular dehiscence, pseu-
dophakodonesis and increased axial length19.
These studies have reported slightly higher incidence estimates compared to our study, which may be related 
to the fact that most patients in these studies needed only IOL repositioning17–20 as opposed to IOL exchange, 
whereas our study focused specifically on IOL removal/exchange. On the other hand such differences may, in 
part, be due to differences in surgical approach (which is partly determined by surgeon’s preference and which we 
could not control for in our retrospective study) to manage eyes with IOL dislocations.
Jin et al. 2007 focused on IOL exchange due to postoperative refractive error20. Incorrect corneal power esti-
mation, followed by error in measurement of axial length and inserting a wrong IOL were the most common 
reasons for IOL exchange20. In this study, we identified 7 eyes that needed IOL exchange due to refractive error 
(Table 3). Of these, 4 had incorrect corneal power estimation related to previous myopic LASIK procedures, lead-
ing to a low postoperative corneal power. This, in turn, tends to lead to an underestimation of the effective lens 
position (ELP) and therefore to an underestimation of the correct IOL power for emmetropia. Of the 3 remaining 
eyes, one had preoperative axial length measure using ultrasound instead of optical biometry, because of mature 
cataract. Ultrasound tends to lead to an underestimation of the correct axial length and subsequent overestima-
tion of the correct IOL power, due to compression of the globe during the ultrasound examination.
The indications for IOL removal/exchange have been examined in several previous studies. Davies et al. found 
that the indications IOL exchange were IOL dislocation to the posterior pole, dissatisfaction with multifocal 
IOL and uveitis9. In a study by Chan et al., the most important indication for in the bag IOL exchange were IOL 
decentration, caused by complicated surgeries, and high myopia11. The most common indication for sulcus IOL 
exchange was glaucoma-hyphema-uveitis syndrome, especially for the one-piece IOL11. Jones et al. found that 
IOL dislocation, refractive error, patient dissatisfaction and implant opacification were the main indications for 
IOL exchange10. Neuhann et al. presented results of 105 eyes from 100 patients undergoing IOL exchange/explant. 
Characteristic Number %
Indication
  In the bag subluxation 8 23.5
  Out of the bag subluxation 7 20.6
  Refractive error 7 20.6
  Uveitis 6 17.6
  Opacification of intraocular lens 3 8.8
  Corneal decompensation 2 5.9
  Trauma 1 2.9
Location of re-implanted IOL
  Sulcus 9 26.5
  In the bag 8 23.5
  Iris fixated 5 14.7
  Scleral fixated 5 14.7
  Anterior chamber 4 11.8
  Aphakia 3 8.8
Table 3. Indication for IOL exchange and location of re-implanted IOL after cataract surgery (n = 34 eyes of 34 
patients).
Best corrected visual acuity at the last 
follow up




Freq (%) Freq (%) Crude Adjusted
IOL exchange/





Control (n = 47 eyes) 39(83.0) 8 (17.0) 1.0 1.0
Table 4. Best corrected visual acuity at most recent follow up in eyes that had an IOL exchange/explantation 
after cataract surgery, and in control eyes that had cataract surgery only. *Adjusted for baseline BCVA using 
Cox’s regression. P values for crude and adjusted RR = 0.008 and 0.025. **Of the 34 eyes in the IOL exchange/
explantation group, 11(32.4%) and 7(20.6%) had a BCVA <20/60–20/200 and <20/200, respectively. By 
contrast, of 47 eyes in the control group, 6(12.8%) and 2 (4.3%) had a BCVA <20/60–20/200 and <20/200, 
respectively.
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In their study, the main indication was subluxation with IOL dislocation, especially associated with pseudoex-
foliation syndrome12. Incorrect IOL power calculation, calcification and corneal endothelial decompensation 
were also found12. In our study, the most common indication for IOL exchange/removal was also IOL dislocation 
(Table 3).
Jakobsson et al. 2013 examined the outcomes after surgical repositioning of IOLs after late dislocation and 
found that 94% could be repositioned using scleral sutures. Pseudoexfoliation was detected in 57% of the eyes, 
which was also reflected in the present study, where ocular comorbidity including pseudexfoliation, was an inde-
pendent risk factor for IOL exchange (Table 2). They found that 13 eyes (out of 91) had additional surgical pro-
cedures, and 3 of those had postoperative retinal detachments. More than half of the eyes obtained visual acuities 
more than 20/40 and 23% of the eyes had a decrease in the visual acuity following the surgery21. In our study, eyes 
that underwent IOL exchange were nearly two and a half times more likely to have a final visual acuity of <20/60 
compared to the control eyes (Table 4).
Kamiya et al. found that the most common complaints for multifocal IOL removal were waxy vision, glare and 
halos, blurred vision (at far, at near, or at intermediate distances), and dysphotopsia,. The most common reasons 
for multifocal IOL removal were decreased contrast sensitivity, followed by photic phenomenon, unknown ori-
gin including neuroadaptation failure, incorrect IOL power, preoperative excessive expectation, IOL dislocation/
decentration, and anisometropia. The mean ± SD axial length was 25.13 ± 1.83 mm in their study22. Myopia was 
also overrepresented in the IOL removal/exchange group in our study, and 4 of the patients had undergone pre-
vious LASIK for high myopia (>6D), leading to difficulties in estimating the central corneal power. However, in 
our final multivariable model, axial length, when used as a categorical variable, did not turn out to be significantly 
associated with IOL exchange, although it was significant when used as a continuous variable (data not shown). 
This is possibly because of a relatively limited sample size in our study (Table 2).
In our study, the presence of an intraoperative adverse event and a pre-existing ocular co-morbidity (such 
as pseudexfoliations) were significant predictors of IOL exchange. This finding generally concur with existing 
literature and is plausible.
Limitations of this study include its retrospective design and the inability to control or adjust for variabil-
ity regarding surgeons preferred technique of IOL exchange or choice of IOL exchange versus IOL reposition. 
The figure of two IOL exchanges/removals per 1000 cataract surgeries may be an underestimate given that the 
follow-up time after cataract surgery was at most 8 years in our study. For the calculation of cumulative incidence 
of an event, the specified time interval should generally be the same for all members of a group. However, it may 
vary in certain situations23. A sufficiently large multi-center prospective study is warranted to more accurately 
estimate the true incidence of IOL exchange/removal and other rare complications of cataract surgery and to 
examine their risk factors and visual outcomes.
We conclude that IOL exchange is rare yet may affect the final visual outcome adversely. The most frequent 
indication was IOL dislocation. Two factors were significantly associated with IOL exchange/explantation: an 
adverse event during cataract surgery, and a pre-existing ocular comorbidity. Eyes that underwent IOL exchange 
or explantation were nearly two and a half time times more likely to have a final visual acuity of <20/60 compared 
to those that had cataract surgery alone.
Methods
This retrospective study was undertaken at the King Khaled Eye Specialist Hospital, Riyadh, a tertiary eye care 
hospital. Ethics approval was obtained from the Institutional Review Board of KKESH. Informed consent for 
intraocular surgery was obtained from all patients. The research followed the tenets of the Declaration of Helsinki. 
A cohort design was employed to estimate the incidence of IOL exchange and a case-control design was used to 
identify factors associated with it.
The main outcome was the cumulative incidence of IOL exchange which was defined as the number of eyes 
that underwent IOL exchange/explantation, divided by the total number of eyes that underwent cataract surgery 
with IOL during the study period23. To achieve this objective, all eyes that underwent phacoemulsification cata-
ract surgery with IOL implantation during 2010–2017 and had a subsequent IOL removal or replacement during 
the same time period were included in the study. Eyes that underwent phakic IOL removal with phacoemulsifi-
cation and IOL were excluded. Diagnostic coding was used to identify the total number of cataract surgeries with 
IOL and those that had a subsequent exchange/explantation.
For the risk-factor component of the study, all eyes that underwent IOL exchange (n = 34) were compared 
with a subset of eyes that had cataract surgery alone (n = 47) during the same period. Specifically, a control eye/
patient for a given case eye/patient was selected from the complete list of entries coded as “phacoemulsification 
with IOL”, where the first entry fulfilling the criterion of age matching the patients age ±5 years, was selected as 
a control.
A structured proforma (Supplemental File 1) was used to collect data from medical records on age, gender, 
pre-operative characteristics, indication for IOL exchange/explantation, the type of IOL that was removed, oper-
ative and postoperative complications, and visual outcomes.
All case and control eyes had baseline preoperative IOL calculations using Zeiss IOL Master 500 (Carl Zeiss 
Meditec, AG Jena, Germany), except where hazy media (such as mature cataract) precluded the use of optical 
biometry. In such cases, applanation ultrasound biometry (Cinescan S or Aviso, Quantel Medical Cedex - France) 
was used to estimate the axial length. The Holladay 2 formula was routinely used as the standard IOL calculation 
formula. However other formulas could be requested in addition, at the discretion of the surgeon. Emmetropia or 
mild myopia was the refractive target for all patients and controls. Visual acuity was measured in Snellen format.
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Statistical analysis. All data were entered in a Microsoft Excel (Microsoft Corporation, Redmond, WA, 
USA) database by a trained data entry operator and analyzed using SPSS for Windows version 20.0 (IBM SPSS, 
Inc., Chicago, IL, USA). For the present analysis, pre-existing ocular comorbities were grouped into binary cate-
gories with “Yes” indicating the presence of the condition and “No” otherwise, as were the pre-existing systemic 
comorbidities, adverse event during cataract surgery, type of surgery, and IOL position. Age was categorized 
as ≤59 years and ≥60 years, and axial length as ≤25 mm and ≥26 mm. Counts and percentages were used to 
describe categorical data and means (with SD) were computed to describe continuous variables.
A binary logistic regression analysis was performed to identify factors associated with IOL exchange/explanta-
tion. Odds ratios (OR) with 95% confidence intervals (CI) were calculated to indicate an association. Nine varia-
bles were examined in the univariate analysis. Of these, adverse event during cataract surgery, pre-existing ocular 
comorbidity, axial length, type of surgery and IOL position were significantly associated with IOL exchange/
explantation. Both type of surgery and IOL position were not considered for the multivariable logistic regression 
models as they were strongly associated with an adverse event during cataract, as indicated by a high phi coeffi-
cients of 0.63 and 0.71, respectively. The final model included adverse event during cataract surgery, pre-existing 
ocular comorbidity, and axial length was adjusted for gender due to slight gender imbalance between case and 
control eyes.
Next, the best-corrected visual acuity (BCVA) at the last follow up was compared between eyes with and 
without subsequent IOL exchange/explantation. Using cox regression analysis, relative risk (RR) with 95% CIs 
were calculated to determine the association between IOL exchange/explantation and BCVA <20/60 at the last 
follow up. For all the analyses, 2-sided p-values were calculated. A p-value < 0.05 was considered significant. 
Supplemental File 1: data collection form and Supplemental File 2: Excel datasheet are appended.
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